NYSEARCA:SYNB Putnam BioRevolution ETF (SYNB) Price, Holdings, & News $28.58 -0.24 (-0.83%) Closing price 07/18/2025 04:10 PM EasternExtended Trading$28.56 -0.02 (-0.07%) As of 07/18/2025 04:10 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisChartHoldingsRatingsBuy This Stock About Putnam BioRevolution ETF (NYSEARCA:SYNB) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get SYNB alerts:Sign Up Key Stats Today's Range$28.58▼$28.5850-Day Range$27.29▼$29.3952-Week Range$24.57▼$33.23Volume3,481 shsAverage Volume169 shsMarket Capitalization$5.00 millionAssets Under Management$5.00 millionDividend Yield0.73%Net Expense Ratio0.71%Aggregate RatingModerate Buy ETF Overview The Putnam BioRevolution ETF (SYNB) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund actively invests in companies of all sizes around the globe that enable biological innovation. SYNB was launched on Sep 29, 2022 and is managed by Putnam. Read More Putnam BioRevolution ETF ExpensesTypeSYNBTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFsManagement Fee0.70%0.57%0.56%0.51%0.53%Other Expenses0.01%0.57%0.56%0.59%0.56%Total Expense0.71%0.74%0.76%0.74%0.73%Fee Waiver0.00%-0.76%-0.66%-0.71%-0.63%Net Expense0.71%0.60%0.63%0.58%0.60% Receive SYNB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Putnam BioRevolution ETF and its competitors with MarketBeat's FREE daily newsletter. Email Address SYNB ETF News HeadlinesNo headlines for this company have been tracked by MarketBeat.com SYNB ETF - Frequently Asked Questions How have SYNB shares performed this year? Putnam BioRevolution ETF's stock was trading at $29.57 at the start of the year. Since then, SYNB stock has decreased by 3.3% and is now trading at $28.58. How do I buy shares of Putnam BioRevolution ETF? Shares of SYNB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Fund Details IssuerPutnam Investments Fund NamePutnam BioRevolution ETF Tax ClassificationRegulated Investment Company Stock ExchangeNYSEARCACurrent SymbolNYSEARCA:SYNB Inception Date9/29/2022 Fund ManagerWilliam Rives WebN/A PhoneN/AFund Focus Asset ClassEquity BenchmarkN/A CategoryStrategy FocusTheme Development LevelBlended Development RegionGlobal Number of Holdings38 Fund Statistics Assets Under Management$5.00 million Average Daily Volume$0.00 Discount/Premium0.00% Administrator, Advisor and Custodian AdministratorState Street Bank and Trust Company AdvisorPutnam Investment Management, LLC CustodianState Street Bank and Trust Company DistributorForeside Fund Services, LLC Transfer AgentState Street Bank and Trust Company TrusteeN/A Lead Market MakerRBC Capital Markets Options OptionableN/A Short Interest100 shs Miscellaneous Outstanding Shares175,000Beta1.04 Creation Fee$250.00 10 Stocks Set to Soar in Summer 2025Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.Get This Free Report Top 10 SYNB HoldingsThermo Fisher Scientific (NYSE:TMO)Holding Weight: 6.92%Corteva (NYSE:CTVA)Holding Weight: 6.38%Novozymes A/S (OTCMKTS:NVZMY)Holding Weight: 6.09%AbbVie (NYSE:ABBV)Holding Weight: 5.19%Bio-Rad Laboratories (NYSE:BIO)Holding Weight: 4.80%NVIDIA (NASDAQ:NVDA)Holding Weight: 4.75%AstraZeneca (NASDAQ:AZN)Holding Weight: 4.46%Ascendis Pharma A/S (NASDAQ:ASND)Holding Weight: 4.29%Zoetis (NYSE:ZTS)Holding Weight: 4.03%Eli Lilly and Company (NYSE:LLY)Holding Weight: 3.82%Full Holdings DetailsSYNB Sector ExposureSYNB Industry Exposure This page (NYSEARCA:SYNB) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Putnam BioRevolution ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Putnam BioRevolution ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free SYNB Stock Alerts